Literature DB >> 15286403

Up-regulation of mu-opioid receptors in the spinal cord of morphine-tolerant rats.

Subrata Basu Ray1, Himanshu Gupta, Yogendra Kumar Gupta.   

Abstract

Though morphine remains the most powerful drug for treating pain, its effectiveness is limited by the development of tolerance and dependence. The mechanism underlying development of tolerance to morphine is still poorly understood. One of the factors could be an alteration in the number of micro-receptors within specific parts of the nervous system. However, reports on changes in the micro-opioid receptor density in the spinal cord after chronic morphine administration are conflicting. Most of the studies have used subcutaneously implanted morphine pellets to produce tolerance. However, it does not simulate clinical conditions, where it is more common to administer morphine at intervals, either by injections or orally. In the present study, rats were made tolerant to morphine by injecting increasing doses of morphine (10-50 mg/kg, subcutaneously) for five days. In vitro tissue autoradiography for localization of micro-receptor in the spinal cord was done using [3H]-DAMGO. As compared to the spinal cord of control rats, the spinal cord of tolerant rats showed an 18.8% increase or up-regulation in the density of micro-receptors in the superficial layers of the dorsal horn. This up-regulation of micro-receptors after morphine tolerance suggests that a fraction of the receptors have been rendered desensitized, which in turn could lead to tolerance

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15286403     DOI: 10.1007/BF02702561

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  24 in total

1.  Mu opioid receptors in developing human spinal cord.

Authors:  S B Ray; S Wadhwa
Journal:  J Anat       Date:  1999-07       Impact factor: 2.610

2.  Up-regulation of central mu-opioid receptors in a model of hepatic encephalopathy: a potential mechanism for increased sensitivity to morphine in liver failure.

Authors:  Nora V Bergasa; Richard B Rothman; Erik Mukerjee; John Vergalla; E Anthony Jones
Journal:  Life Sci       Date:  2002-02-22       Impact factor: 5.037

3.  Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.

Authors:  F G Fang; H L Fields; N M Lee
Journal:  J Pharmacol Exp Ther       Date:  1986-09       Impact factor: 4.030

4.  In vivo opiate binding unchanged in tolerant/dependent mice.

Authors:  J Dum; G Meyer; V Höllt; A Herz
Journal:  Eur J Pharmacol       Date:  1979-10-15       Impact factor: 4.432

5.  Acute systemic administration of morphine selectively increases mu opioid receptor binding in the rat brain.

Authors:  J W Lewis; M E Lewis; D J Loomus; H Akil
Journal:  Neuropeptides       Date:  1984-12       Impact factor: 3.286

6.  Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.

Authors:  L M Bohn; R R Gainetdinov; F T Lin; R J Lefkowitz; M G Caron
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

7.  Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats.

Authors:  H N Bhargava; A Gulati
Journal:  Eur J Pharmacol       Date:  1990-11-13       Impact factor: 4.432

8.  Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic study.

Authors:  L S Brady; M Herkenham; J B Long; R B Rothman
Journal:  Brain Res       Date:  1989-01-16       Impact factor: 3.252

9.  Autoradiographic mapping of mu-opioid receptors during opiate tolerance and supersensitivity in the rat central nervous system.

Authors:  A Díaz; A Pazos; J Flórez; M A Hurlé
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-08       Impact factor: 3.000

10.  Up-regulation of [3H]DAMGO and [3H]DTLET opioid binding sites in laminae I-II of the spinal cord in intact and deafferented morphine-tolerant rats.

Authors:  D Besse; M C Lombard; J M Besson
Journal:  Neurosci Lett       Date:  1992-03-02       Impact factor: 3.046

View more
  9 in total

1.  Involvement of protein kinase C in morphine tolerance at spinal levels of rats.

Authors:  Wu-Yang Jin; Long-Chuan Yu
Journal:  ACS Chem Neurosci       Date:  2009-10-05       Impact factor: 4.418

2.  A novel knock-in mouse reveals mechanistically distinct forms of morphine tolerance.

Authors:  Johan Enquist; Joseph A Kim; Selena Bartlett; Madeline Ferwerda; Jennifer L Whistler
Journal:  J Pharmacol Exp Ther       Date:  2011-05-11       Impact factor: 4.030

3.  The interaction between the mu opioid receptor and filamin A.

Authors:  Eric J Simon; Irma Onoprishvili
Journal:  Neurochem Res       Date:  2010-09-21       Impact factor: 3.996

Review 4.  Diels-Alder Adducts of Morphinan-6,8-Dienes and Their Transformations.

Authors:  János Marton; Anikó Fekete; Paul Cumming; Sándor Hosztafi; Pál Mikecz; Gjermund Henriksen
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

5.  Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A.

Authors:  Irma Onoprishvili; Eric J Simon
Journal:  Brain Res       Date:  2007-08-16       Impact factor: 3.252

6.  Involvement of Neuropeptide Y in Post-Incisional Nociception in Rats.

Authors:  Shivani Gupta; Mayank Gautam; Pranav Prasoon; Rahul Kumar; Subrata Basu Ray; Saroj Kaler Jhajhria
Journal:  Ann Neurosci       Date:  2018-12-04

7.  Intrathecal catheterization and drug delivery in rats to compare the analgesic effects of morphine with ketorolac.

Authors:  Subrata Basu Ray; Roman Saini; Rakesh Kumar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-01

8.  The Contribution of the Descending Pain Modulatory Pathway in Opioid Tolerance.

Authors:  Lindsay M Lueptow; Amanda K Fakira; Erin N Bobeck
Journal:  Front Neurosci       Date:  2018-11-27       Impact factor: 4.677

9.  Intrathecal Co-administration of Morphine Facilitated the Anti-nociceptive of Bupivacaine in a Rat Model of Acute Postoperative Pain.

Authors:  Tamoghna Ghosh; Subrata Basu Ray
Journal:  Cureus       Date:  2022-08-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.